Stocks to buy

Are There Opportunities Right Now in the Biotech Sector?

The biotech market has not been faring well recently. This is mainly due to the fact that these companies are the paragon of  “we don’t make money today.” So, while they develop potentially life-changing drugs and technology, it’s all about the monetary value of the products in the future.

Companies reliant on future cash flows, like biotech stocks, were hit especially hard in the market selloff.

But for companies with good technical signs and fundamentals, we’re still seeing great buying opportunities in the sector.

About 90 biotech stocks are trading below their cash positions. This simply means they’re trading below the amount of cash they have on their balance sheet.

This is an all-time high for the sector, which peaked at 20 stocks in 2009. But a broader uptrend started in the summer of 2015 and will continue to rise over time.

In short, the biotech sector is technically oversold but fundamentally undervalued. And this is creating some great buying opportunities right now.

Watch the full episode at Hypergrowth Investing on YouTube.

Articles You May Like

Beware! Why the Recent NIO Stock Rally Could Be Fleeting
Stocks making the biggest moves midday: Carvana, Colgate-Palmolive, Tesla and more
Stocks making the biggest moves midday: GM, McDonald’s, UPS, Pulte, International Paper and more
Top Wall Street analysts like these stocks for maximum returns
7 Sorry EV Stocks to Sell in February Before It’s Too Late